These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33390349)

  • 21. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myeloma care adaptations in the UK during SARS-CoV-2 pandemic: Challenges and measurable outcomes.
    Djebbari F; Panitsas F; Sharpley FA; Rampotas A; Larham J; Moore S; Gooding S; Kothari J; Ramasamy K
    Eur J Haematol; 2020 Nov; 105(5):662-666. PubMed ID: 32592210
    [No Abstract]   [Full Text] [Related]  

  • 23. A Case of Multiple Myeloma in a 17-Year-Old Girl Treated with Autologous Hematopoietic Stem Cell Transplantation (ASCT).
    Man HV; Dung PC
    Am J Case Rep; 2019 Nov; 20():1623-1629. PubMed ID: 31685790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Porphyria cutanea tarda (type 1) in HIV infection].
    Hoegl L; Thoma-Greber E; Röcken M
    Hautarzt; 1996 Jan; 47(1):58-61. PubMed ID: 8835006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NCCN: Multiple myeloma.
    Traynor AE; Noga SJ;
    Cancer Control; 2001; 8(6 Suppl 2):78-87. PubMed ID: 11760563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple myeloma associated with porphyria cutanea tarda: a possible role of bortezomib?
    Cabanillas M; Peteiro C; Toribio J
    Dermatology; 2006; 213(3):246-7. PubMed ID: 17033179
    [No Abstract]   [Full Text] [Related]  

  • 27. Is autologous stem cell transplantation still relevant for multiple myeloma?
    Choi T
    Curr Opin Hematol; 2019 Nov; 26(6):386-391. PubMed ID: 31567432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in pre- and post-transplant therapies with first autologous hematopoietic cell transplantation among patients with multiple myeloma in the United States, 2004-2014.
    D'Souza A; Zhang MJ; Huang J; Fei M; Pasquini M; Hamadani M; Hari P
    Leukemia; 2017 Sep; 31(9):1998-2000. PubMed ID: 28663578
    [No Abstract]   [Full Text] [Related]  

  • 29. Subcutaneous bortezomib incorporated into the bortezomib-thalidomide-dexamethasone regimen as part of front-line therapy in the context of autologous stem cell transplantation for multiple myeloma.
    Lok A; Mocquard J; Bourcier J; Redelsperger L; Bonnet A; Chauvin C; Thomaré P; Mahé B; Touzeau C; Moreau P
    Haematologica; 2014 Mar; 99(3):e33-4. PubMed ID: 24532044
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy.
    Kyle RA
    Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and survival of 338 multiple myeloma patients treated with hematopoietic stem cell transplantation or conventional chemotherapy.
    Pérez R; Durán MS; Mayans J; Soler A; Castillo I; Jurado M; Ribas P; Menchaca Echevarria MC; Hernandez MT; Lopez Garcia-Carreño MD; Echeveste Gutierrez A; Bailen Garcia A; Lopez S; Baquero J; Ramirez G
    Eur J Haematol; 2016 Apr; 96(4):417-24. PubMed ID: 26190662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyria cutanea tarda in a patient with hepatitis C.
    Gómez Moyano E; Martínez Pilar L; Fernandez Ballesteros MD; Godoy Diaz DJ
    Med Clin (Barc); 2018 Feb; 150(3):e5. PubMed ID: 28416230
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic myelogenous leukemia and porphyria cutanea tarda in a patient with limited systemic sclerosis.
    Wooten MD; Scott JW; Miller AM; Boh E
    South Med J; 1998 May; 91(5):493-5. PubMed ID: 9598864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Solarium-induced pseudoporphyria and variegate porphyria as rare differential diagnoses of porphyria cutanea tarda].
    Kochs C; Mühlenstädt E; Neumann NJ; Hanneken S
    Hautarzt; 2009 Oct; 60(10):790-3. PubMed ID: 19756434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.
    Martino M; Morabito F
    Expert Opin Biol Ther; 2015 Feb; 15(2):149-54. PubMed ID: 25435056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sclerodermiform porphyria cutanea tarda.
    Amezyane T; Abouzahir A; Fatihi J; Sekkach Y; Mahassin F; Sedrati O; Ghafir D; Ohayon V
    Intern Med; 2010; 49(2):205-6. PubMed ID: 20075595
    [No Abstract]   [Full Text] [Related]  

  • 38. Porphyria cutanea tarda in a patient with HIV-infection.
    Almehmi A; Deliri H; Szego GG; Teague AC; Pfister AK; Martin SA
    W V Med J; 2005; 101(1):19-21. PubMed ID: 15861867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porphyria cutanea tarda preceding AIDS.
    Ash S; Woodley DT; Chan LS
    Lancet; 1996 Jan; 347(8995):190. PubMed ID: 8544558
    [No Abstract]   [Full Text] [Related]  

  • 40. Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma.
    Marneni N; Chakraborty R
    Curr Hematol Malig Rep; 2021 Apr; 16(2):148-161. PubMed ID: 33876390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.